These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1944198)
1. [The present status and the future of artificial liver support]. Kasai S; Hirai S; Sawa M; Kakisaka A; Yamamoto T; Mito M Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1249-52. PubMed ID: 1944198 [TBL] [Abstract][Full Text] [Related]
2. [Artificial liver support systems: state of the art]. Pazzi P; Scagliarini R Ann Ital Chir; 2000; 71(3):319-23. PubMed ID: 11014011 [TBL] [Abstract][Full Text] [Related]
3. [Hybrid (bioartificial) systems for liver support. History and current developments]. Morsiani E Ann Ital Chir; 2000; 71(3):311-8. PubMed ID: 11014010 [TBL] [Abstract][Full Text] [Related]
4. [An artificial liver on its way to clinical reality?]. Thasler WE; Koebe HG; Pahernik SA; Schildberg FW Zentralbl Chir; 1995; 120(8):614-23. PubMed ID: 7571893 [TBL] [Abstract][Full Text] [Related]
7. [Bioartificial liver support system: state of the art]. Xiong W; Li Y; Cheng J Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Feb; 21(1):146-50. PubMed ID: 15022487 [TBL] [Abstract][Full Text] [Related]
10. Is the biological artificial liver clinically applicable? A historic review of biological artificial liver support systems. Kasai S; Sawa M; Mito M Artif Organs; 1994 May; 18(5):348-54. PubMed ID: 8037608 [TBL] [Abstract][Full Text] [Related]
11. [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure]. Wang YJ; He NH; Niu RZ; Liu J; Wen HW; Li JJ; Wang YM Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):461-3. PubMed ID: 12939175 [TBL] [Abstract][Full Text] [Related]
12. Proceedings: Biocompatibility in a system of artificial liver support for fulminant hepatic failure. Weston MJ; Gazzard BG; Langley PG; Dunlop EH; Williams R Gut; 1974 Apr; 15(4):342. PubMed ID: 4834578 [No Abstract] [Full Text] [Related]
13. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Mai G; Nguyen TH; Morel P; Mei J; Andres A; Bosco D; Baertschiger R; Toso C; Berney T; Majno P; Mentha G; Trono D; Buhler LH Xenotransplantation; 2005 Nov; 12(6):457-64. PubMed ID: 16202069 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation. Tabei I; Hashimoto H; Ishiwata I; Tachibana T; Akahori M; Ohi S; Kubo H; Satou K; Yamazaki Y; Yanaga K; Ishikawa H Transplant Proc; 2005; 37(1):262-4. PubMed ID: 15808614 [TBL] [Abstract][Full Text] [Related]
15. Prolonged artificial liver support in a child with fulminant hepatic failure. Okamoto K; Kurose M; Ikuta Y; Ogata K; Harada T; Takeda K; Sato T ASAIO J; 1996; 42(3):233-5. PubMed ID: 8725697 [TBL] [Abstract][Full Text] [Related]
16. [Medical aspects of the artificial liver]. Neuhaus P; Steffen R Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():301-7. PubMed ID: 2577560 [TBL] [Abstract][Full Text] [Related]
17. Effects of plasma from patients with fulminant hepatic failure on function of primary rat hepatocytes in three-dimensional culture. Nagaki M; Naito T; Ohnishi H; Akaike T; Muto Y; Moriwaki H Liver Int; 2005 Oct; 25(5):1010-7. PubMed ID: 16162161 [TBL] [Abstract][Full Text] [Related]